InspireMD (NSPR) Stock News
$NSPR · NASDAQ · HEALTHCARE · 5 stories in 30 daysBORSA has published 5 stories on InspireMD (NSPR) in the past 30 days, 3 of them high impact. BORSA’s news read on NSPR is bullish at 59/100, based on 5 company events over the past 7 days. NSPR last closed at $0.77 on Nov 12, up 21.13% over five sessions and up 65.31% over the past month. InspireMD last reported quarterly results on Aug 14, 2026, for the quarter ended Jun 30, 2026.
The wire on $NSPR
newest first · updated · direct subject stories onlyInspireMD receives FDA approval for CGuard Prime in TCAR procedures, expects to double US addressable market
InspireMD receives FDA approval for CGuard Prime in TCAR procedures, expects to double US addressable market.
bullish 85 · impact 70InspireMD announces proposed public offering of common stock
InspireMD (NSPR) announced a proposed public offering of common stock. The offering is subject to market conditions and will dilute existing shareholders.
bearish 25 · impact 70